Alpha 2.0
Login Register
» Articles » PMID: 34310097

Psoriasis-like Eruption Triggered by Dupilumab Therapy

Overview
Journal Dermatitis
Publisher Mary Ann Liebert
Specialty Dermatology
Date 2021 Jul 26
PMID 34310097
Citations 7
Authors
Filomena Russo
Luca Provvidenziale
Francesco Bruzziches
Diletta Fiorani
Francesco Santi
Arianna Lamberti
Laura Lazzeri
Maria Laura Flori
Pietro Rubegni
Affiliations
Soon will be listed here.
Citing Articles

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective.

Guglielmo A, Deotto M, Naldi L, Stinco G, Pileri A, Piraccini B Dermatol Reports. 2024; 16(2):9839.

PMID: 38957642 PMC: 11216152. DOI: 10.4081/dr.2023.9839.

"De Novo" Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature.

Trave I, Salvi I, Burlando M, Cozzani E, Parodi A J Clin Med. 2023; 12(19).

PMID: 37834935 PMC: 10573833. DOI: 10.3390/jcm12196291.

Inhibition of IL-17 ameliorates keratinocyte-borne cytokine responses in an in vitro model for house-dust-mite triggered atopic dermatitis.

Haertle J, Kienlin P, Begemann G, Werfel T, Roesner L Sci Rep. 2023; 13(1):16628.

PMID: 37789035 PMC: 10547677. DOI: 10.1038/s41598-023-42595-z.

Prurigo Nodularis onset during secukinumab treatment of psoriasis: a case report.

Yang Q, Lyu J, Gui Y, Yu S, Chen J, Zhang H Allergy Asthma Clin Immunol. 2023; 19(1):59.

PMID: 37408052 PMC: 10324148. DOI: 10.1186/s13223-023-00811-5.

Psoriasis-like skin rash triggered by a local infection in a patient with eosinophilic granulomatosis with polyangiitis that was well controlled by mepolizumab treatment.

Yokota N, Kondo M, Hayashi A, Ichishi M, Matsushima Y, Nakanishi T Clin Case Rep. 2023; 11(6):e7532.

PMID: 37305885 PMC: 10256866. DOI: 10.1002/ccr3.7532.